iBio News

News

Ticker

IBIO

ISIN

US4510337086

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

iBio Eulerpool News

1/3/2025, 5:03:59 PM

iBio stärkt Präsenz im Biotech-Sektor durch strategische Partnerschaft mit AstralBio

iBio Stock News

iBio is being monitored by journalists and investors worldwide. We gather the latest iBio news here.

March 17·
SeekingAlpha
iBio, Inc. (IBIO) Discusses Bispecific Antibody Program and Rationale for Targeting Pulmonary Hypertension in Heart Failure Transcript
March 16·
Benzinga
iBio, Inc. To Host Call On PH-HFpEF Pipeline Expansion, Targets Bispecific Antibody Candidate Selection In Q3 2026
March 9·
Benzinga
iBio Reports Early Study Results Showing Experimental Obesity Drug Reduced Fat in Animals
March 3·
Benzinga
Jones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7
February 27·
Benzinga
iBio Enters $100M At-The-Market Offering Agreement With Jefferies LLC; Terminates Prior $7.35M ATM Program
February 27·
Benzinga
iBio Files Preliminary Prospectus To Issue Up To $200M In Securities
February 24·
Yahoo
iBio to Participate in Upcoming Investor Conferences
February 12·
Benzinga
Chardan Capital Maintains Buy on iBio, Maintains $5 Price Target
February 10·
Yahoo
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
February 10·
Benzinga
iBio Earnings Review: Q2 Summary
February 3·
Yahoo
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?
February 2·
Yahoo
iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
January 30·
Benzinga
iBio Files Prospectus For Resale Of 11,061,738 Shares Of Common Stock By Selling Stockholders
January 9·
Benzinga
iBio shares are trading higher after the company announced a $26 million private placement.
January 9·
Yahoo
iBio Announces $26 Million Private Placement
January 9·
Benzinga
iBio Announces Private Placement Of Approximately $26M
December 20·
Yahoo
iBio Insiders Placed Bullish Bets Worth US$655.0k
December 17·
Benzinga
EcoR1 Capital Reports 9.9% Passive Stake In IBio As Of Dec 10
December 10·
Yahoo
BC-Most Active Stocks
December 10·
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session

iBio Stock Press Releases

iBio regularly publishes news on the company's website that are relevant for investors.

August 16•
iBio
iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate
May 18•
iBio
iBio to Participate in the H.C. Wainwright Global Investment Conference
May 12•
iBio
iBio Reports Fiscal Third Quarter 2022 Financial Results and Provides Corporate Update
May 9•
iBio
iBio Demonstrates Efficacy of an IL-2 Sparing Anti-CD25 Antibody Produced Using its FastPharming System for Treg Depletion in Cancer
May 5•
iBio
iBio to Report Fiscal 2022 Third Quarter Financial Results and Provide Corporate Update on Thursday, May 12, 2022
May 2•
iBio
iBio Announces Presentation Highlighting Superior Glycosylation for Antibodies Produced in Plants
March 11•
iBio
iBio to Participate in the Oppenheimer 32nd Annual Healthcare Conference
February 15•
iBio
Pipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors
February 14•
iBio
iBio Reports Fiscal Second Quarter 2022 Financial Results and Provides Corporate Update
February 7•
iBio
iBio to Report Fiscal 2022 Second Quarter Financial Results and Provide Corporate Update on Monday, February 14, 2022
January 26•
iBio
iBio Announces Progression of Vaccine Program for Multi-Variant COVID-19 Disease
January 4•
iBio
iBio Announces Participation in the H.C. Wainwright BioConnect Conference
December 22•
iBio
iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022
December 21•
iBio
iBio Provides Information for Listening to the Virtual Annual Stockholder Meeting
December 10•
iBio
iBio Announces Partial Adjournment of Annual Meeting to December 22
November 30•
iBio
ISS Joins Glass Lewis in Recommending Shareholders Vote “FOR” All Proposals Ahead of iBio’s Upcoming Annual Meeting
November 29•
iBio
Omicron Variant Underscores Need for New COVID Vaccine Candidates Like IBIO-202
November 17•
iBio
Leading Independent Proxy Advisory Firm, Glass Lewis, Recommends iBio Shareholders Vote “FOR” All Proposals Ahead of Annual Meeting
November 15•
iBio
iBio Reports Fiscal First Quarter 2022 Financial Results and Provides Corporate Update
November 15•
iBio
iBio Announces Collaboration with UT Southwestern to Investigate IBIO-100 in Solid Tumors
November 8•
iBio
iBio to Report Fiscal 2022 First Quarter Financial Results and Provide Corporate Update on Monday, November 15, 2021
November 3•
iBio
iBio Acquires FastPharming Manufacturing Facility®
October 26•
iBio
iBio Urges Shareholders to Vote “FOR” All Proposals Ahead of its Upcoming Annual Meeting to be Held on December 9
September 27•
iBio
iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update
September 20•
iBio
iBio to Participate in the Cantor 2021 Virtual Global Healthcare Conference
September 20•
iBio
iBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Monday, September 27, 2021
September 7•
iBio
iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conference
August 26•
iBio
iBio Appoints William D. Clark to its Board of Directors
August 25•
iBio
iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics
July 15•
iBio
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate

iBio News 2026

This page contains all current news, analysis and press releases for iBio stock (IBIO, ISIN: US4510337086). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at iBio.